Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB17685ExperimentalGene Therapies
LB-001 is a gene editing therapy designed to incorporate a functioning version of the faulty methylmalonyl-COA mutase (MUT) gene into the genome of patients with methylmalonic acidemia.
- Code names
- LB-001
Which companies are running trials of LB-001, in which indications and phases, and which of those programs are still active?